Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Zelenectide Pevedotin in Participants With NECTIN4 Amplified Advanced Breast Cancer

NCT06840483 is registered in ClinicalTrials.gov with BicycleTx Limited as lead sponsor.

NCT NCT06840483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06840483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Zelenectide Pevedotin in Participants With NECTIN4 Amplified Advanced Breast Cancer
Lead sponsor
BicycleTx Limited
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 3, 2025
Completion date
December 30, 2028
Enrollment
66 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer